Skip to main content
Tech.euFundingExplorerBeta

TreeFrog Therapeutics

TreeFrog Therapeutics is a biotechnology company that develops regenerative medicine and cell therapies using a 3D biomimetic platform.

TreeFrog Therapeutics has raised €71M across 2 funding rounds from 4 investors, most recently a Series B round in Sep 2021. Based in Bordeaux, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€71M
€70,767,233
Funding rounds
2
Investors
4
distinct backers
Active since
2019-04
latest 2021-09

Funding by year

EUR raised per year
TreeFrog Therapeutics — funding by year — interactive chart.
Data table
TreeFrog Therapeutics — funding by year
2019€7.1M
2021€64M

Signals

High confidence
Raise-next likelihood10
base rate 48% for Series B
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 7y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2021-09-13Series B€64MBpifrance Large Venture,Bristol Myers Squibb,Leonard Green & Partners,XAngeView deal →
2019-04-01Series A€7.1MXAngeView deal →

Similar companies

same sector or country

Global coverage: FundingData